Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
Cano A, Ettcheto M, Chang JH, Barroso E, Espina M, Kühne BA, Barenys M, Auladell C, Folch J, Souto EB, Camins A, Turowski P, García ML. Cano A, et al. J Control Release. 2019 May 10;301:62-75. doi: 10.1016/j.jconrel.2019.03.010. Epub 2019 Mar 13. J Control Release. 2019. PMID: 30876953 Free PMC article.
Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice.
Ettcheto M, Cano A, Manzine PR, Busquets O, Verdaguer E, Castro-Torres RD, García ML, Beas-Zarate C, Olloquequi J, Auladell C, Folch J, Camins A. Ettcheto M, et al. Among authors: cano a. Mol Neurobiol. 2020 Apr;57(4):1814-1827. doi: 10.1007/s12035-019-01849-6. Epub 2019 Dec 14. Mol Neurobiol. 2020. PMID: 31838720
Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer's disease in metabolically stressed APPswe/PS1dE9 mice.
Ettcheto M, Sánchez-Lopez E, Cano A, Carrasco M, Herrera K, Manzine PR, Espinosa-Jimenez T, Busquets O, Verdaguer E, Olloquequi J, Auladell C, Folch J, Camins A. Ettcheto M, et al. Among authors: cano a. Cell Biosci. 2021 Jul 22;11(1):141. doi: 10.1186/s13578-021-00646-w. Cell Biosci. 2021. PMID: 34294142 Free PMC article.
A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer's disease exacerbated with high fat diet.
Espinosa-Jiménez T, Cano A, Sánchez-López E, Olloquequi J, Folch J, Bulló M, Verdaguer E, Auladell C, Pont C, Muñoz-Torrero D, Parcerisas A, Camins A, Ettcheto M. Espinosa-Jiménez T, et al. Among authors: cano a. Cell Biosci. 2023 Mar 9;13(1):52. doi: 10.1186/s13578-023-01000-y. Cell Biosci. 2023. PMID: 36895036 Free PMC article.
The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer's Dementia.
Folch J, Olloquequi J, Ettcheto M, Busquets O, Sánchez-López E, Cano A, Espinosa-Jiménez T, García ML, Beas-Zarate C, Casadesús G, Bulló M, Auladell C, Camins A. Folch J, et al. Among authors: cano a. Front Aging Neurosci. 2019 Sep 6;11:236. doi: 10.3389/fnagi.2019.00236. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31551756 Free PMC article.
Masitinib for the treatment of Alzheimer's disease.
Ettcheto M, Cano A, Sanchez-López E, Verdaguer E, Folch J, Auladell C, Camins A. Ettcheto M, et al. Among authors: cano a. Neurodegener Dis Manag. 2021 Aug;11(4):263-276. doi: 10.2217/nmt-2021-0019. Epub 2021 Aug 20. Neurodegener Dis Manag. 2021. PMID: 34412534 Review.
Impact of New Drugs for Therapeutic Intervention in Alzheimer's Disease.
Olloquequi J, Ettcheto M, Cano A, Sanchez-López E, Carrasco M, Espinosa T, Beas-Zarate C, Gudiño-Cabrera G, Ureña-Guerrero ME, Verdaguer E, Folch J, Auladell C, Camins A. Olloquequi J, et al. Among authors: cano a. Front Biosci (Landmark Ed). 2022 May 6;27(5):146. doi: 10.31083/j.fbl2705146. Front Biosci (Landmark Ed). 2022. PMID: 35638413 Free article. Review.
Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations.
Espinosa-Jiménez T, Busquets O, Cano A, Sánchez-López E, Verdaguer E, Parcerisas A, Olloquequi J, Auladell C, Folch J, Wahli W, Vázquez-Carrera M, Camins A, Ettcheto M. Espinosa-Jiménez T, et al. Among authors: cano a. Front Pharmacol. 2022 Jul 11;13:902047. doi: 10.3389/fphar.2022.902047. eCollection 2022. Front Pharmacol. 2022. PMID: 35899125 Free PMC article.
1,161 results